IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,405,305 | -15.1% | 214,575 | +1.0% | 0.00% | 0.0% |
Q2 2023 | $4,010,798 | +1029.4% | 212,549 | +129.8% | 0.00% | – |
Q1 2023 | $355,142 | -16.9% | 92,485 | +7.3% | 0.00% | – |
Q4 2022 | $427,508 | +5.3% | 86,191 | +1.5% | 0.00% | – |
Q3 2022 | $406,000 | +15.0% | 84,955 | +8.2% | 0.00% | – |
Q2 2022 | $353,000 | -7.1% | 78,492 | -1.7% | 0.00% | – |
Q1 2022 | $380,000 | -34.4% | 79,880 | +2.4% | 0.00% | – |
Q4 2021 | $579,000 | +35.3% | 78,043 | +3.2% | 0.00% | – |
Q3 2021 | $428,000 | +74.7% | 75,610 | +103.6% | 0.00% | – |
Q2 2021 | $245,000 | -18.3% | 37,129 | +0.1% | 0.00% | – |
Q1 2021 | $300,000 | +40.2% | 37,077 | +11.7% | 0.00% | – |
Q4 2020 | $214,000 | +60.9% | 33,193 | -9.9% | 0.00% | – |
Q3 2020 | $133,000 | -35.1% | 36,831 | -17.3% | 0.00% | – |
Q2 2020 | $205,000 | +36.7% | 44,519 | +1.1% | 0.00% | – |
Q1 2020 | $150,000 | -25.4% | 44,016 | +11.7% | 0.00% | – |
Q4 2019 | $201,000 | +120.9% | 39,420 | +4.8% | 0.00% | – |
Q3 2019 | $91,000 | +56.9% | 37,617 | +41.6% | 0.00% | – |
Q2 2019 | $58,000 | -19.4% | 26,572 | 0.0% | 0.00% | – |
Q1 2019 | $72,000 | -43.8% | 26,572 | 0.0% | 0.00% | – |
Q4 2018 | $128,000 | -41.3% | 26,572 | +15.8% | 0.00% | – |
Q3 2018 | $218,000 | +9.0% | 22,951 | +11.6% | 0.00% | – |
Q2 2018 | $200,000 | -1.0% | 20,559 | +7.2% | 0.00% | – |
Q1 2018 | $202,000 | +27.0% | 19,184 | -21.6% | 0.00% | – |
Q4 2017 | $159,000 | -2.5% | 24,459 | +13.6% | 0.00% | – |
Q3 2017 | $163,000 | -11.4% | 21,526 | -16.2% | 0.00% | – |
Q2 2017 | $184,000 | +85.9% | 25,685 | 0.0% | 0.00% | – |
Q1 2017 | $99,000 | +94.1% | 25,685 | -8.5% | 0.00% | – |
Q4 2016 | $51,000 | +27.5% | 28,065 | +88.9% | 0.00% | – |
Q3 2016 | $40,000 | -40.3% | 14,858 | -31.6% | 0.00% | – |
Q2 2016 | $67,000 | -64.4% | 21,724 | 0.0% | 0.00% | – |
Q1 2016 | $188,000 | -27.1% | 21,724 | +13.2% | 0.00% | – |
Q4 2015 | $258,000 | +38.0% | 19,186 | 0.0% | 0.00% | – |
Q3 2015 | $187,000 | +8.1% | 19,186 | +55.7% | 0.00% | – |
Q2 2015 | $173,000 | +53.1% | 12,320 | 0.0% | 0.00% | – |
Q1 2015 | $113,000 | +46.8% | 12,320 | 0.0% | 0.00% | – |
Q4 2014 | $77,000 | -43.0% | 12,320 | 0.0% | 0.00% | – |
Q3 2014 | $135,000 | – | 12,320 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 10,906,962 | $69,914,000 | 3.04% |
Fernwood Investment Management, LLC | 224,500 | $1,439,000 | 0.77% |
Telemetry Investments, L.L.C. | 272,000 | $1,744,000 | 0.66% |
Schonfeld Strategic Advisors LLC | 865,356 | $5,547,000 | 0.45% |
Virtus ETF Advisers LLC | 53,977 | $346,000 | 0.43% |
Endurant Capital Management LP | 210,800 | $1,351,000 | 0.41% |
SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $3,205,000 | 0.38% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $726,000 | 0.37% |
Orbimed Advisors | 2,834,126 | $18,167,000 | 0.23% |
PINNACLE ASSOCIATES LTD | 1,322,231 | $8,476,000 | 0.16% |